#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4418408	B	Inhibition of untagged human USP30 catalytic domain (57 to 517 residues) expressed in Escherichia coli using TAMRA labeled ubiquitin peptide as substrate preincubated for 30 min followed by substrate addition and measured after 2 hrs by fluorescence polarization assay	Homo sapiens	272		assay format	Patent Bioactivity Data
2.	ALA4418409	B	Inhibition of human USP30 catalytic domain (57 to 517 residues) using ubiquitin-rhodamine 110 as substrate preincubated for 30 min followed by substrate addition and measured after 2 hrs by fluorescence intensity kinetic assay	Homo sapiens	272		single protein format	Patent Bioactivity Data
3.	ALA4418444	B	Inhibition of untagged human USP30 catalytic domain (57 to 517 residues) expressed in Escherichia coli using TAMRA labeled ubiquitin peptide as substrate preincubated for 30 min followed by substrate addition and measured after 2 hrs by fluorescence polarization assay	Homo sapiens	78		assay format	Patent Bioactivity Data
4.	ALA4418459	B	Inhibition of untagged human USP30 catalytic domain (57 to 517 residues) expressed in Escherichia coli using TAMRA labeled ubiquitin peptide as substrate preincubated for 30 min followed by substrate addition and measured after 2 hrs by fluorescence polarization assay	Homo sapiens	67		assay format	Patent Bioactivity Data
5.	ALA4418460	B	Inhibition of untagged human USP30 catalytic domain (57 to 517 residues) expressed in Escherichia coli using TAMRA labeled ubiquitin peptide as substrate preincubated for 30 min followed by substrate addition and measured after 2 hrs by fluorescence polarization assay	Homo sapiens	27		assay format	Patent Bioactivity Data
6.	ALA4418461	B	Inhibition of untagged human USP30 catalytic domain (57 to 517 residues) expressed in Escherichia coli using TAMRA labeled ubiquitin peptide as substrate preincubated for 30 min followed by substrate addition and measured after 2 hrs by fluorescence polarization assay	Homo sapiens	77		assay format	Patent Bioactivity Data
7.	ALA4418477	B	Inhibition of USP30 (unknown origin) using ubiquitin-rhodamine 110 as substrate preincubated for 15 mins followed by substrate addition and measured after 2 hrs by fluorescence based assay	Homo sapiens	90		single protein format	Patent Bioactivity Data
8.	ALA4605986	B	Inhibition of human USP30 CD (57 to 517 residues) expressed in Escherichia coli assessed as cleavage of Ubiquitin-Rhodamine110-glycine to Ubiquitin and Rhodamine110-glycine using Ubiquitin-Rhodamine110-glycine as substrate by fluorescence based analysis	Homo sapiens	1		assay format	Scientific Literature
9.	ALA4674624	B	Inhibition of USP30 (unknown origin)	Homo sapiens	2		single protein format	Scientific Literature
10.	ALA4674628	B	Inhibition of USP30 (unknown origin) using Ubiquitin-Rhodamine110-Glycine as substrate incubated for 15 mins followed by substrate addition and measured after 2 hrs by fluorescence based assay	Homo sapiens	48		single protein format	Scientific Literature
11.	ALA5108414	B	Inhibition of GST-tagged recombinant USP30 (unknown origin) using Ub-Lys-TAMRA as substrate at 1 uM incubated for 30 mins by fluorescence polarization assay	Homo sapiens	2		single protein format	Scientific Literature
12.	ALA5223299	B	Inhibition of USP30 (unknown origin)	Homo sapiens	1		single protein format	Scientific Literature
13.	ALA5251107	B	Inhibition of human USP30 (57 to 517 residues) expressed in Sf9 cells using ubiquitin rhodamine 110 as substrate assessed as remaining enzyme activity at 10 to 50 uM by fluorometric assay	Homo sapiens	1		cell-based format	Scientific Literature
14.	ALA5251142	B	Inhibition of human USP30 using ubiquitin rhodamine 110 as substrate at 10 to 50 uM by fluorometric assay	Homo sapiens	1		single protein format	Scientific Literature
15.	ALA5251164	B	Inhibition of USP30 (unknown origin) using ubiquitin rhodamine 110 as substrate at 1 to 10 uM by DUBprofiler fluorometric assay	Homo sapiens	2		single protein format	Scientific Literature